Detalhe da pesquisa
1.
First-in-human randomized controlled trial of an oral, replicating adenovirus 26 vector vaccine for HIV-1.
PLoS One
; 13(11): e0205139, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30427829
2.
Assessment of Anti-HIV-1 Antibodies in Oral and Nasal Compartments of Volunteers From 3 Different Populations.
J Acquir Immune Defic Syndr
; 73(2): 130-7, 2016 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27243901
3.
A Phase 1 study to evaluate the safety and immunogenicity of a recombinant HIV type 1 subtype C-modified vaccinia Ankara virus vaccine candidate in Indian volunteers.
AIDS Res Hum Retroviruses
; 25(11): 1107-16, 2009 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-19943789
4.
Induction of multifunctional human immunodeficiency virus type 1 (HIV-1)-specific T cells capable of proliferation in healthy subjects by using a prime-boost regimen of DNA- and modified vaccinia virus Ankara-vectored vaccines expressing HIV-1 Gag coupled to CD8+ T-cell epitopes.
J Virol
; 80(10): 4717-28, 2006 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-16641265